Skip to main content

Month: January 2023

Junshi Biosciences Announces Acceptance of NDA for VV116 in China

SHANGHAI, China, Jan. 17, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the new drug application (“NDA”) for Deuremidevir Hydrobromide Tablets (project code: JT001/VV116, “VV116”), an oral nucleoside analog anti-SARS-CoV-2 drug, has been accepted by the National Medical Products Administration (the “NMPA”) for the treatment of the coronavirus disease 2019 (“COVID-19”). About Junshi BiosciencesFounded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics. The company...

Continue reading

Junshi Biosciences Announces Toripalimab as Perioperative Treatment for Operable NSCLC Patients Met Primary Endpoint in Phase 3 Clinical Study

SHANGHAI, China, Jan. 18, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that a randomized, double-blind, placebo-controlled, multi-center phase III clinical study (“Neotorch”, NCT04158440) of the company’s anti-PD-1 monoclonal antibody, toripalimab, in combination with platinum-containing doublet chemotherapy as perioperative treatment for operable non-small cell lung cancer (“NSCLC”) patients, has finished the pre-specified interim analysis. The Independent Data Monitoring Committee (IDMC) has determined that the primary endpoint of event-free survival (“EFS”) has met the pre-defined efficacy boundary. Junshi Biosciences...

Continue reading

Pilgrim’s Pride Corporation to Host Year End 2022 Earnings Call on February 9, 2023

GREELEY, Colo., Jan. 17, 2023 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) announced today that it will release its fourth quarter and fiscal year 2022 financial results after the U.S. market closes on Wednesday, February 8, 2023. The Company’s executives will review the results on a conference call and webcast on Thursday, February 9, 2023 at 7:00 a.m. MT (9:00 a.m. ET). Prepared remarks regarding the company’s financial and operational results will be followed by a question and answer period with Pilgrim’s executive management team. Investors and analysts may pre-register for the webcast to receive a unique PIN to gain immediate access to the call and bypass the live operator. Pre-registration may be completed at any time, including up to and after the call has begun, by accessing the company’s investor website...

Continue reading

Bombardier Announces Pricing of its New Issuance of Senior Notes due 2029

MONTRÉAL, Jan. 17, 2023 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has successfully priced its offering of US$750 million aggregate principal amount of new Senior Notes due February 1, 2029. The new Senior Notes will carry a coupon of 7.50% per annum and will be sold at par (the “New Notes”). The issuance of the New Notes is expected to close on or about January 20, 2023, subject to customary closing conditions. Bombardier intends to use the proceeds of the offering of the New Notes, together with cash on hand, (i) to fund the redemption of all of its outstanding 7.500% Senior Notes due 2024 (the “2024 Notes”), of which there is $396 million aggregate principal amount outstanding on the date hereof, (ii) to finance the offer to purchase (the “2025 Tender Offer”) up to $354 million aggregate principal...

Continue reading

Bombardier Increases the Maximum Amount Sought Under its Cash Tender Offer Previously Announced Today

MONTRÉAL, Jan. 17, 2023 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier” or the “Company”) today announced an amendment with respect to its cash tender offer previously announced on January 17, 2023 (the “Tender Offer”) to purchase for cash up to $104,000,000 aggregate principal amount (exclusive of accrued and unpaid interest, and as such aggregate principal amount may be increased or decreased by the Company, the “Aggregate Maximum Principal Amount”) of its outstanding 7.50% Senior Notes due 2025 (the “Notes”). Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Offer to Purchase dated January 17, 2023 (as amended hereby, the “Offer to Purchase”) with respect to the Tender Offer. The Tender Offer and the Offer to Purchase are hereby amended as follows:The Aggregate Maximum Principal...

Continue reading

Construction Equipment Market Size to Hit $223.1 billion by 2027 – Exclusive Report by MarketsandMarkets™

Chicago, Jan. 17, 2023 (GLOBE NEWSWIRE) — Construction Equipment Market is estimated to grow from USD 180.4 billion in 2022 to reach USD 223.1 billion by 2027, at a CAGR of 4.3% over the forecast period, according to a new report by MarketsandMarkets™.  Browse in-depth TOC on “Construction Equipment Market”    470 – Tables 72 – Figures       486 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id= 179948937Report Attributes DetailsMarket size value in 2022:  USD 180.4 BillionProjected to reach 2027:  USD 223.1 BillionCAGR:  4.3%Base Year Considered:  2021Forecast Period:  2022-2027Largest Market:  Asia PacificRegion Covered: Asia Oceania, Europe, North America, and RoWSegments Covered: Equipment Type, Equipment...

Continue reading

Burning Rock provides an update on 2022 revenue guidance

GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it expects the Company’s full-year revenue growth for 2022 to be approximately 10% compared to that of 2021. This represents an upward revision compared with the Company’s previous guidance on the full-year revenue growth of 5% as announced on November 15, 2022 in its financial results for the third quarter of 2022. The upward revision of revenue guidance was primarily driven by a better fourth quarter performance compared to the Company’s estimation underlying its previous guidance back in November. The Company currently expects its revenues for the...

Continue reading

American Assets Trust, Inc. Releases Tax Status of 2022 Distributions

SAN DIEGO, Jan. 17, 2023 (GLOBE NEWSWIRE) — American Assets Trust, Inc. (NYSE: AAT) (the “Company”) announced today the tax treatment of its 2022 dividend distributions as follows: Security Descriptions: Common StockCUSIP: 024013104Ticker Symbol: AATRecord Date Payable Date Total Distribution Per Share Allocable to 2022 Taxable Ordinary Dividend LT Capital Gain Unrecaptured Sec. 1250 Gain Section 199A Dividends Return of Capital03/10/22 03/24/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.02519606/09/22 06/23/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.02519609/08/22 09/22/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.02519612/08/22 12/22/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.025196  Total $1.28 $1.28 $1.179216 $0.000000 $0.000000 $1.179216 $0.100784The...

Continue reading

Freshii Files Management Information Circular for Special Meeting of Shareholders

TORONTO, Jan. 17, 2023 (GLOBE NEWSWIRE) — Freshii Inc. (TSX: FRII) (“Freshii” or the “Company”) today announced that it has filed and is in the process of mailing the Management Information Circular and related materials for the special meeting of Freshii’s shareholders, which will be held virtually at 9:00 a.m. (Toronto time) on February 8, 2023 via live audio webcast as more particularly set out in the meeting materials. At the meeting, shareholders will be asked to consider the previously announced plan of arrangement pursuant to which Foodtastic Inc. will acquire all of the issued and outstanding Class A subordinate voting shares and Class B multiple voting shares in the capital of Freshii and such other business as may properly come before the meeting or any adjournment or postponement thereof. The Circular and related meeting...

Continue reading

SmartCentres Declares Distribution for January 2023

TORONTO, Jan. 17, 2023 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of January 2023 of CDN $0.15417 per trust unit, representing CDN $1.85 per unit on an annualized basis. Payment will be made on February 15, 2023 to unitholders of record on January 31, 2023. About SmartCentres SmartCentres Real Estate Investment Trust is one of Canada’s largest fully integrated REITs, with a best-in-class portfolio featuring 185 strategically located properties in communities across the country. SmartCentres has approximately $11.9 billion in assets and owns 34.7 million square feet of income producing value-oriented retail and first-class office space with 98.1% occupancy, on 3,500 acres of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.